Torres-Cabala, Carlos A

Carlos A. Torres-Cabala is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research integrates dermatopathology, cutaneous biology, and oncology, focusing on melanoma, cutaneous lymphomas, and rare adnexal neoplasms. Recent work includes biomarker analyses of neoadjuvant relatlimab and nivolumab in resectable melanoma, the characterization of a novel RNF11::BRAF fusion, and the validation of INSM1 as a superior marker for Merkel cell carcinoma. He has also described an FGFR1 fusion in aggressive epidermotropic T-cell lymphoma and explored TROP2 expression as a therapeutic target in squamous cell carcinomas.